CClinicalTrials.gg
RecruitingNCT04164940Updated Nov 24, 2023

Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems

An observational study in Alcohol Consumption, Alcohol; Harmful Use and Health Risk Behaviors, sponsored by Helse Stavanger HF. Recruiting at 1 site in Norway. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2023-11-24.

Sponsored by Helse Stavanger HF · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Oct 2019; still recruiting 6 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
500
Ages
21 Years and older
Sex
All
01

Study summary

Alcohol is contributing to many health problems and disorders, as well as accidents and social problems. Alcohol consumption has been on the rise the past 25 years, especially in Norway. The highest increase is found in older adults, in line with the development in most other countries in the western world. Older adults have a higher risk for alcohol related health problems, due to age related physiological changes, medical conditions and medications. Still, alcohol use is seldom addressed for older people. This means that older people rarely receive help to change alcohol habits.

Norwegian health authorities have issued mandates ordering the regional health trusts to implement strategies in somatic hospital wards, mental health services and drug treatment services to identify and treat alcohol and drug problems affecting the patients' health.

In this observational study we will explore patient trajectories three years prior to and three years after an admittance to hospital where risky or harmful alcohol consumption is identified and brief interventions are delivered. Hospitals that have implemented such strategies are invited to the study. Patient trajectories are studied in national health registries. This will provide important knowledge on what characterizes the patients identified, and what happens after they have received a brief intervention related to a hospital admittance.

Read the detailed description

This is a multi-centre registry study in Norwegian medical and surgical hospitals. The project is focusing on patients aged 60+, receiving an intervention for alcohol-related health problems in somatic hospital wards in one year, and without a previous history of referral or treatment in specialized health care for an alcohol or drug problem. Other age groups of adults will be used as control groups. The included patients will also be their own control group, where we compare registry data on the trajectories three years following the alcohol intervention with registry data from the three years preceding the intervention.

The recruited hospitals will have different strategies for identification of and interventions for alcohol-related health problems, and the choice of methods is thus outside of our control. All inhabitants in Norway are registered with a personal identification number. This individual identifier makes the linkage between the participants and the different registries possible. Data from these registries will enable the study of serious incidents, as well as of diagnoses, medications and other treatments, welfare and benefits, and causes of death. Data will be gathered three years retrospectively and 3 years prospectively, related to the index hospital stay where alcohol is addressed and a brief intervention is delivered.

Inclusion criteria for patients are age 21+, no previous treatment history for drug or alcohol problems in specialized health care, admitted to medical or surgical hospital ward, identified risky or harmful alcohol consumption, accepting an alcohol intervention and accepting study participation. Baseline data collected are AUDIT C, question no 10 from the full AUDIT and classification of alcohol consumption (risky or harmful). All other variables are extracted from the national health registries (reimbursement data from primary health care and secondary health care, prescription database, Cause of death registry, Norwegian Trauma Registry and social security data, marital status, professional status).

02

Conditions studied

  • Alcohol Consumption
  • Alcohol; Harmful Use
  • Health Risk Behaviors
  • Alcohol Dependence
03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's planned enrollment of 500 is above the median of 180 across 173 observational studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Helse Stavanger HF is the lead sponsor of 93 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients 21 years or older admitted to medical or surgical hospital wards offering some kind of screening and brief alcohol intervention as part of the daily routine, and without a prior diagnosis of AUD or SUD.

Inclusion criteria

  • Age 21 or older, no previous alcohol use disorder or substance use disorder, admitted to hospital which has implemented screening and brief alcohol intervention strategies, written consent to participate

Exclusion criteria

Exclusion Criteria:

  • specialized treatment for alcohol use disorder og drug use disorder during the three years prior to recruitment
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
500 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • Age 21-30

    Patients aged 21-30 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 31-40

    Patients aged 31-40 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 41-50

    Patients aged 41-50 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 51-60

    Patients aged 51-60 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 61-70

    Patients aged 61-70 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 71-80

    Patients aged 71-80 when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

  • Age 81 and older

    Patients aged 81 and older when admitted to hospital and receiving brief alcohol intervention

    Other: Brief alcohol intervention

Interventions

  • OtherBrief alcohol intervention

    Brief alcohol intervention already implemented in daily routine by the individual hospitals.

06

What researchers measure

Primary outcomes

  1. Alcohol use disorder (AUD)

    Diagnosis of AUD after recruitment in the study

    Time frame: Three years

  2. Prescriptions for AUD

    Prescriptions for the treatment of alcohol use disorder

    Time frame: Three years

Secondary outcomes

  1. Health care

    Diagnoses and procedures in primary and secondary health care

    Time frame: Three years

  2. Trauma

    Serious trauma registered in trauma registry

    Time frame: Three years

  3. Death

    Death and cause of death

    Time frame: Three years

  4. Prescriptions for addictive drugs

    Prescriptions for any drug with addictive potential

    Time frame: Three years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04164940
Lead sponsor
Helse Stavanger HF
Collaborators
Helse Vest, Helse Fonna, Helse Møre og Romsdal HF, Sorlandet Hospital HF, Helse Sor-Ost, Lovisenberg Diakonale Hospital, Oslo University Hospital, Vestre Viken Hospital Trust
Responsible party
Sponsor
First posted
Nov 15, 2019
Start date
Oct 23, 2019
Primary completion
Dec 2023 (estimated)
Completion
Dec 2030 (estimated)
Last update
Nov 24, 2023

Study contacts

Torgeir G Lid, MD PhD
Contact
torgeir.gilje.lid@sus.no
+47 48187477
Vendela M Husberg-Bru, MS
Contact
vendela.husberg-bru@sus.no
+47 40541456
Torgeir G Lid, MD PhD
principal investigator · Helse Stavanger HF

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion